Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Pain|March 26, 2014
Inhibition of c-Kit signaling is associated with reduced heat and cold pain sensitivity in humansMarta Ceko, Nevena Milenkovic, Philipp le Coutre, et al.
Onkologie|September 16, 2006
Long-lasting remission of pulmonary metastases of renal cell cancer under IFN-beta therapy in a patient with multiple sclerosisAnne Flörcken, Timm Denecke, Albrecht Kretzschmar, et al.
European Journal of Immunology|March 15, 2018
FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cellsLivius Penter, Kerstin Dietze, Lars Bullinger, et al.
Deutsche Medizinische Wochenschrift (1946)|October 18, 2016
[Flow-cytometric immunophenotyping in clinical diagnostics]Benjamin Nils Ostendorf, Leo Hansmann, Wolf-Dieter Ludwig, et al.
Human Vaccines & Immunotherapeutics|February 12, 2016
DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional propertiesAnne Flörcken, Joachim Kopp, Uwe Kölsch, et al.
British Journal of Haematology|December 24, 2005
Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemiaJörg Westermann, Antje Lessen, Claudia Schlimper, et al.
Oncoimmunology|July 7, 2017
The splenic marginal zone shapes the phenotype of leukemia B cells and facilitates their niche-specific retention and survivalVanessa Stache, Lydia Verlaat, Marcel Gätjen, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2003
Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional propertiesJörg Westermann, Ida J Körner, Joachim Kopp, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
Anti-leukemia T cells in AML: TNF-α⁺ CD8⁺ T cells may escape detection and possibly reflect a stage of functional impairmentAnne Flörcken, Antje van Lessen, Theis H Terwey, et al.
Anti-Cancer Drugs|December 14, 2011
Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinomaAnne Flörcken, Anna Takvorian, Antje Van Lessen, et al.
Pageof 7